“Staying Ahead of the Curve in Diagnostics Policy”, Webinar via Life Science TN
You're Invited to a Life Science TN Webinar
Staying Ahead of the Curve in Diagnostics Policy
Thursday, September 1
9:30 – 11 a.m. CT
The BRET Office will be streaming this webinar live from Light Hall 415C. Please plan to join us if you are interested (no need for a Life Science TN membership)!
How will CMS reimburse for clinical diagnostic laboratory tests?
What new and proposed FDA regulations could affect the life sciences innovation pipeline?
Join us for a thought-provoking conversation as we delve into these and other pressing policy issues facing the diagnostics industry. On September 1, Life Science Tennessee is hosting a conversation between Hedgeye health care analyst Emily Evans and Gillian Hooker, head of federal policy at local diagnostics company NextGxDx.
The webinar is free for Life Science Tennessee members and $25 for non-members.
We will continue to explore the impact of federal policy on the diagnostics space leading up to the LST|CON event this coming fall.
Dr. Gillian Hooker,
Vice President of Clinical Development
Dr. Hooker is the Vice President of Clinical Development with the Nashville-based diagnostics technology company, NextGxDx, which builds software tools to support genetic test ordering and reimbursement. She is active in research projects exploring trends in genetic testing, including the integration of nextgen sequencing technologies and its subsequent impact on the genetic testing market, genetic counseling and clinical care.
Senior Healthcare Policy Analyst
Hedgeye Risk Management
Emily is a Senior Healthcare Policy Analyst at Hedgeye Risk Management. Prior to joining Hedgeye Risk Management, Emily was a partner at Obsidian Research, a healthcare research boutique that she founded. She has over three decades of professional experience working both in and around government.
Life Science TN website: http://www.lifesciencetn.org/events/EventDetails.aspx?id=847065